Log in to save to my catalogue

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal...

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6890447

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer

About this item

Full title

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2019-12, Vol.110 (12), p.3727-3737

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Abnormal function of human body enzymes and epigenetic alterations such as DNA methylation have been shown to lead to human carcinogenesis. Lysyl oxidase (LOX) enzyme has attracted attention due to its involvement in tumor progression in various cancers. The purpose of this study was to clarify the clinical importance of LOX expression and its epig...

Alternative Titles

Full title

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6890447

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6890447

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.14214

How to access this item